Related Experiment Video

Updated: Aug 8, 2026

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
06:47

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

Hypertension and left ventricular hypertrophy

J M Krzesinski1, G Rorive, H Van Cauwenberge

  • 1Service de Néphrologie, C.H.U. Sart Tilman, Liège, Belgium.

Acta Cardiologica
|January 1, 1996
PubMed

Insights

Left ventricular hypertrophy, an abnormal heart structure in hypertension, is a risk factor for heart issues. Reversing this condition with blood pressure treatment may improve outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiac Physiology

Background:

  • Left ventricular hypertrophy (LVH) is a cardiac adaptation to high blood pressure.
  • The structure of hypertrophied myocardium in hypertension is abnormal and influenced by various factors.
  • LVH is an independent risk factor for adverse cardiovascular events, including sudden death, arrhythmias, ischemia, and heart failure.

Purpose of the Study:

  • To investigate the characteristics and implications of left ventricular hypertrophy in hypertension.
  • To explore the factors influencing the prevalence and anatomical pattern of LVH.
  • To assess the potential benefits of antihypertensive treatment in reversing LVH.

Main Methods:

  • Non-invasive detection and precise characterization of LVH and its anatomical pattern using echocardiography.
  • Analysis of factors influencing LVH prevalence, including age, gender, weight, race, genetics, and hypertension severity.
  • Review of existing literature on hemodynamic and non-hemodynamic factors affecting cardiac remodeling.

Main Results:

  • Echocardiography enables accurate, non-invasive assessment of LVH and its non-uniform anatomical patterns.
  • Hypertension-induced LVH is associated with diastolic dysfunction early in the disease progression.
  • LVH significantly increases the risk of sudden death, arrhythmias, myocardial ischemia, and heart failure.

Conclusions:

  • Left ventricular hypertrophy in hypertension is a significant independent risk factor for severe cardiovascular complications.
  • Reversibility of LVH through antihypertensive treatment is suggested to be beneficial, supported by preliminary data.
  • Further research is needed to fully elucidate the mechanisms of cardiac remodeling and the impact of treatment.

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...